BioNTech SE - ADR vs DraftKings Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while DraftKings Inc trades at $25.3 (market cap $12.58B). The key difference: BioNTech SE - ADR is the larger of the two by market cap. Which is the better fit depends on your goals.
| BNTX | DKNG | |
|---|---|---|
Market Cap | $23.31B | $12.58B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $48.23 |
52-Week Low | $83.89 | $20.72 |
Enterprise Value | $6.60B | $13.51B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →